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Abstract  
  
Proteomics encompasses a suite of techniques for generating datasets on proteins and their functions in 
biological systems. The talk will provide an overview of how proteomics can be used for analysis of proteins for 
lead generation in pharmaceutical research and how the type of information derived can feed forward into 
biochemical models – from individual pathways to whole cells – demonstrated using specific examples including 
analysis of disease pathways and of bacterial production recombinant proteins. The focus will be on proteomics 
as an enabling set of quantitative technologies for chemical engineering of biological systems and mathematical 
/ computational approaches to biology. 
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